# Astrana Health, Inc.: Form 10-Q/A for the period ended Mar 31, 2023

- Company: [Astrana Health, Inc.](/companies/asth.md) (CIK 1083446)
- Form: 10-Q/A
- Filed: 2023-08-09
- Accepted by EDGAR: Aug 9, 2023, 17:26 ET
- Period: 2023-03-31
- Accession: 0001628280-23-028677
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1083446/000162828023028677/ameh-20230331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1083446/000162828023028677/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2023-01-01 to 2023-03-31 | $337.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Operating income | 3 months, 2023-01-01 to 2023-03-31 | $22.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2023-01-01 to 2023-03-31 | $3.3m | us-gaap:InterestExpense |
| Income tax | 3 months, 2023-01-01 to 2023-03-31 | $6.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2023-01-01 to 2023-03-31 | $13.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2023-01-01 to 2023-03-31 | $0.28 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2023-01-01 to 2023-03-31 | $0.28 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2023-01-01 to 2023-03-31 | 46,954,687 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2023-01-01 to 2023-03-31 | $7.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2023-01-01 to 2023-03-31 | $6.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months, 2023-01-01 to 2023-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2023-03-31 | $274.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2023-03-31 | $454.7m | us-gaap:AssetsCurrent |
| Total assets | at 2023-03-31 | $998.9m | us-gaap:Assets |
| Current liabilities | at 2023-03-31 | $173.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2023-03-31 | $433.7m | us-gaap:Liabilities |
| Long-term debt | at 2023-03-31 | $204.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2023-03-31 | $621.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2023-03-31 | $548.3m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1083446/000162828023028677/ameh-20230331.htm

Filed Aug 9, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-028677. Last ingested by Listed: Nov 14, 2026, 19:58 ET. No prices; not investment advice.
